SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-23-000003
Filing Date
2023-02-09
Accepted
2023-02-09 14:55:09
Documents
74
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20221231x10q.htm   iXBRL 10-Q 2138956
2 EX-31.1 veru-20221231xex31_1.htm EX-31.1 15660
3 EX-31.2 veru-20221231xex31_2.htm EX-31.2 15976
4 EX-32.1 veru-20221231xex32_1.htm EX-32.1 11904
  Complete submission text file 0000863894-23-000003.txt   8901817

Data Files

Seq Description Document Type Size
5 EX-101.SCH veru-20221231.xsd EX-101.SCH 51860
6 EX-101.CAL veru-20221231_cal.xml EX-101.CAL 69463
7 EX-101.DEF veru-20221231_def.xml EX-101.DEF 160977
8 EX-101.LAB veru-20221231_lab.xml EX-101.LAB 398358
9 EX-101.PRE veru-20221231_pre.xml EX-101.PRE 331210
68 EXTRACTED XBRL INSTANCE DOCUMENT veru-20221231x10q_htm.xml XML 1946785
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 23605719
SIC: 2834 Pharmaceutical Preparations